Federal appeals court rejects NIH research funding cuts
Source: SeekingAlpha
2026-01-06 07:16:59 ET
More on Thermo Fisher Scientific, Danaher, etc.
- Thermo Fisher: Refinding Some Momentum
- Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value
- Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- Thermo Fisher upgraded at Citi on boost in pharma spending
- Waters raised to Outperform at Wolfe on BD Life Sciences deal
Read the full article on Seeking Alpha
For further details see:
Federal appeals court rejects NIH research funding cuts
Tecan Group AG ADR
NASDAQ: TCGGY
TCGGY Trading
100.0% G/L:
$35.7275 Last:
13 Volume:
$0 Open:
